Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerResumen de Investigación
Analyzed using Evidence Intelligence™
Emotion-focused strategies reduce diabetes distress and improve HbA1c
Última actualización 9 de septiembre de 2026
Key finding
Cohen's d = 0.58–1.14
This study evaluated the impact of three pharmaceutical interventions on diabetes distress and HbA1c levels in adults with type 1 diabetes.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the impact of three pharmaceutical interventions on diabetes distress and HbA1c levels in adults with type 1 diabetes.
Clinical relevance
These findings are significant for clinicians managing type 1 diabetes, as they highlight effective strategies to reduce diabetes-related stress and improve glycemic control, which can lead to better overall health outcomes for patients.
Keep in mind
Effectiveness of interventions remains unclear due to unspecified p-values. Results may not be generalizable beyond the study population. Limited information on long-term effects beyond 12 months.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Danielle MH, Lawrence F, Susan G, et al. Diabetes Distress Reduction and HbA1c Improvement in Adults with Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2024;47(8):1370-1378. doi:10.2337/dc23-2452
Efectos Principales
All three programs demonstrated reductions in diabetes distress (Cohen's d = 0.58–1.14) at 12-month follow-up.
All three programs showed reductions in HbA1c levels (range, -0.4 to -0.72) at 12-month follow-up.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to FixIt, Streamline, TunedIn and Diabetes distress scores, HbA1c.
This study contributes evidence to
Primary intervention
FixIt
Primary outcomes
- Diabetes distress scores
- HbA1c
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
6
Evidence pairs
6
Relationships
2
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 64
2
Related topics
6
Evidence pairs
643
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 6 evidence relationships
- Includes primary outcome data
- Linked to 2 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
Diabetes Distress
matched_outcome
Evidencia relacionada
Tema de evidencia
HbA1c Reduction
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- Diabetes distress decreased significantly across all interventions (Cohen's d = 0.58–1.14).
- HbA1c levels reduced by up to 0.72% across all interventions.
A quién se aplica
- Adults diagnosed with type 1 diabetes.
- Individuals experiencing diabetes-related distress.
Tener en Cuenta
- Further research is needed to confirm long-term effectiveness.
- The study's findings may not apply to all demographics.
- Effect sizes should be interpreted with caution due to unclear statistical significance.
Entre Líneas
- Effectiveness of interventions remains unclear due to unspecified p-values.
- Results may not be generalizable beyond the study population.
- Limited information on long-term effects beyond 12 months.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on FixIt and Diabetes Distress Measures, FixIt and HbA1c.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
FixIt → Diabetes Distress Measures
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
View evidenceBehavioral & Lifestyle
FixIt → HbA1c
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
View evidenceIncluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
Diabetes Distress Measures Evidence Hub
All studies measuring Diabetes Distress Measures
1 studies
outcome_hubMeasures Diabetes Distress Measures as a key outcome.
FixIt Evidence Hub
All studies on FixIt
1 studies
intervention_hubContributes to FixIt evidence base.
HbA1c Evidence Hub
All studies measuring HbA1c
1 studies
outcome_hubMeasures HbA1c as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on FixIt and Diabetes distress scores
Intervention: FixItOutcome: Diabetes distress scores
1 results
All studies on FixIt and HbA1c
Intervention: FixItOutcome: HbA1c
1 results
All studies on FixIt
Intervention: FixIt
1 results
All studies measuring Diabetes distress scores
Outcome: Diabetes distress scores
1 results
All studies measuring HbA1c
Outcome: HbA1c
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does FixIt improve diabetes distress scores?
Emerging Evidence
FixIt appears to improve diabetes distress scores.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Diabetes distress scores
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does FixIt lower HbA1c?
Emerging Evidence
FixIt appears to lower HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does Streamline improve diabetes distress scores?
Emerging Evidence
Streamline appears to improve diabetes distress scores.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Diabetes distress scores
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does Streamline lower HbA1c?
Emerging Evidence
Streamline appears to lower HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Adding diabetes medications to metformin improves glycemic control in adults with T2 diabetes.HRS-7535 improves glycemic control in adults with type 2 diabetesLiraglutide and Empagliflozin Improve Heart Function in DiabetesAdding medications improves blood sugar control in diabetes patients.Bariatric surgery improves glucose homeostasis in type 2 diabetes.
Sin anuncios. Sin rastreo.
Centrada en la evidencia, no en la publicidad.
Segura y privada
Tus datos siempre están protegidos.
Siempre al día
Se agregan nuevos estudios todos los días.